New Activation Modus of STAT3
Open Access
- 1 September 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (39), 26377-26384
- https://doi.org/10.1074/jbc.m109.007955
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammationJCI Insight, 2008
- Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisNature, 2006
- Principles of interleukin (IL)-6-type cytokine signalling and its regulationBiochemical Journal, 2003
- Stat2 Binding to the Interferon-α Receptor 2 Subunit Is Not Required for Interferon-α SignalingPublished by Elsevier BV ,2002
- Role of the Intracellular Domain of the Human Type I Interferon Receptor 2 Chain (IFNAR2c) in Interferon SignalingJournal of Biological Chemistry, 2000
- Dissection of Signaling Cascades through gp130 In VivoImmunity, 2000
- Distinct Roles for STAT1, STAT3, and STAT5 in Differentiation Gene Induction and Apoptosis Inhibition by Interleukin-9Journal of Biological Chemistry, 1999
- The Proximal Tyrosines of the Cytoplasmic Domain of the β Chain of the Type I Interferon Receptor Are Essential for Signal Transducer and Activator of Transcription (Stat) 2 ActivationJournal of Biological Chemistry, 1999
- An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STATOncogene, 1997
- SH2 domains recognize specific phosphopeptide sequencesCell, 1993